Early studies suggest heat and humidity may help slow the coronavirus, but not all scientists are convinced

There's been a lot of speculation about whether heat and humidity could help push back the COVID-19 coronavirus, as it tends to do with other coronaviruses, and some early studies suggest that it could indeed be a factor as the Northern Hemisphere prepares for warmer months, The Washington Post reports. But there's still a lot of research to be done.
A new, non-peer reviewed study from the Massachusetts Institute of Technology published over the weekend found that 90 percent of coronavirus transmissions have occurred in areas with temperatures between 37 and 63 degrees and within a specific humidity range. Outside of these zones, the virus is still spreading, but it doesn't seem to move at the exponential rate it does in cooler places. For example, several countries in Southeast Asia which had a rush of visitors from mainland China earlier in the year have not seen outbreaks on the scale of those in Europe and the United States, and many of the cases in countries like Australia are believed to be travel-related. Even in some warmer states like Texas and Florida, the paper notes, are not exhibiting the same growth rates seen in New York and Washington.
Still, this is preliminary research and many scientists aren't convinced. Jeffrey Shaman, the director of Columbia University's climate and health program, urged people not to "put a lot of stock" in the MIT study and said more lab testing is required. Even the authors of the study said the possibility of slower growth rates as the weather warms isn't an excuse to throw caution to the wind, especially because the virus could re-establish itself by the fall. They also suggested countries in the Southern Hemisphere brace themselves as winter approaches. Read more at The Washington Post.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
How Canadian tariffs could impact tourism to the US
In the Spotlight Canadians represent the largest group of foreign visitors to the United States. But they may soon stop visiting.
By Justin Klawans, The Week US Published
-
Entitlements: DOGE goes after Social Security
Feature Elon Musk is pushing false claims about Social Security fraud
By The Week US Published
-
The Week contest: Amazon Bond
Puzzles and Quizzes
By The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published